Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| HIV Antibodies | 8 | 2019 | 776 | 1.87 | Why? |
| HIV-1 | 10 | 2020 | 3365 | 1.12 | Why? |
| Antibodies, Neutralizing | 19 | 2021 | 25288 | 0.67 | Why? |
| HIV Infections | 9 | 2019 | 11620 | 0.60 | Why? |
| Antibodies, Monoclonal | 11 | 2021 | 8041 | 0.52 | Why? |
| Viremia | 3 | 2018 | 1020 | 0.52 | Why? |
| Antibody Affinity | 2 | 2021 | 1078 | 0.31 | Why? |
| Antibodies, Viral | 13 | 2021 | 51949 | 0.23 | Why? |
| Virus Latency | 2 | 2018 | 251 | 0.20 | Why? |
| Proviruses | 1 | 2018 | 82 | 0.18 | Why? |
| Dependovirus | 1 | 2019 | 272 | 0.17 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.16 | Why? |
| Clinical Trials, Phase I as Topic | 1 | 2018 | 242 | 0.16 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 2 | 2018 | 386 | 0.16 | Why? |
| Mutation | 6 | 2021 | 12376 | 0.16 | Why? |
| Recombination, Genetic | 2 | 2020 | 1265 | 0.14 | Why? |
| Spike Glycoprotein, Coronavirus | 10 | 2021 | 37182 | 0.14 | Why? |
| Neutralization Tests | 7 | 2021 | 6698 | 0.14 | Why? |
| CHO Cells | 1 | 2017 | 831 | 0.14 | Why? |
| HIV Envelope Protein gp120 | 1 | 2017 | 267 | 0.14 | Why? |
| Cricetulus | 1 | 2017 | 936 | 0.13 | Why? |
| Epitopes | 6 | 2021 | 4113 | 0.13 | Why? |
| Host-Pathogen Interactions | 3 | 2021 | 11041 | 0.12 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.12 | Why? |
| CD4 Lymphocyte Count | 1 | 2017 | 1517 | 0.11 | Why? |
| Antigens, Viral | 4 | 2021 | 6298 | 0.11 | Why? |
| Leukocytes, Mononuclear | 2 | 2018 | 2115 | 0.11 | Why? |
| Models, Molecular | 5 | 2021 | 7616 | 0.10 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.10 | Why? |
| Anti-Retroviral Agents | 1 | 2018 | 1099 | 0.10 | Why? |
| Viral Load | 3 | 2018 | 15850 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Immunologic Memory | 4 | 2021 | 3362 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.09 | Why? |
| Animals | 6 | 2020 | 78931 | 0.09 | Why? |
| Biosensing Techniques | 1 | 2021 | 2116 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.08 | Why? |
| Peptide Fragments | 1 | 2017 | 2075 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| B-Lymphocytes | 4 | 2021 | 4418 | 0.07 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.07 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4545 | 0.06 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.06 | Why? |
| Cryoelectron Microscopy | 2 | 2021 | 2372 | 0.06 | Why? |
| Humans | 24 | 2021 | 930598 | 0.06 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.06 | Why? |
| Interferometry | 1 | 2021 | 74 | 0.06 | Why? |
| HEK293 Cells | 3 | 2020 | 8394 | 0.06 | Why? |
| New York | 2 | 2021 | 2488 | 0.06 | Why? |
| T-Cell Antigen Receptor Specificity | 1 | 2021 | 93 | 0.06 | Why? |
| Chimera | 1 | 2020 | 83 | 0.05 | Why? |
| Vesiculovirus | 1 | 2020 | 153 | 0.05 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 283 | 0.05 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.05 | Why? |
| Protein Isoforms | 1 | 2020 | 347 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2019 | 7330 | 0.05 | Why? |
| Immunoglobulin M | 3 | 2021 | 9091 | 0.05 | Why? |
| Historically Controlled Study | 1 | 2018 | 71 | 0.05 | Why? |
| HIV Envelope Protein gp160 | 1 | 2018 | 33 | 0.05 | Why? |
| Adult | 11 | 2021 | 244371 | 0.05 | Why? |
| Genes, Reporter | 1 | 2020 | 472 | 0.05 | Why? |
| Reassortant Viruses | 1 | 2020 | 287 | 0.05 | Why? |
| Protein Array Analysis | 1 | 2020 | 387 | 0.04 | Why? |
| Vesicular stomatitis Indiana virus | 1 | 2020 | 354 | 0.04 | Why? |
| Fluorescent Antibody Technique | 1 | 2021 | 835 | 0.04 | Why? |
| Protein Domains | 2 | 2021 | 6563 | 0.04 | Why? |
| Peptide Library | 1 | 2020 | 564 | 0.04 | Why? |
| Binding Sites, Antibody | 1 | 2018 | 466 | 0.04 | Why? |
| Male | 12 | 2021 | 367725 | 0.04 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.04 | Why? |
| Female | 12 | 2021 | 380317 | 0.04 | Why? |
| Selection, Genetic | 1 | 2020 | 691 | 0.04 | Why? |
| Phylogeny | 3 | 2021 | 13341 | 0.04 | Why? |
| Aged | 10 | 2021 | 215776 | 0.04 | Why? |
| HIV Seropositivity | 1 | 2018 | 320 | 0.04 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.04 | Why? |
| Anti-HIV Agents | 2 | 2018 | 2209 | 0.04 | Why? |
| Antibody Specificity | 1 | 2020 | 1328 | 0.04 | Why? |
| HLA Antigens | 1 | 2021 | 830 | 0.04 | Why? |
| Epitope Mapping | 1 | 2020 | 1240 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2018 | 907 | 0.04 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.03 | Why? |
| Protein Multimerization | 1 | 2020 | 1336 | 0.03 | Why? |
| Intestines | 1 | 2021 | 817 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Immunization, Passive | 2 | 2020 | 10067 | 0.03 | Why? |
| Virulence | 1 | 2021 | 2172 | 0.03 | Why? |
| Vero Cells | 2 | 2020 | 14117 | 0.03 | Why? |
| Virus Activation | 1 | 2018 | 480 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 952 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2021 | 1267 | 0.03 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.03 | Why? |
| Drug Resistance, Viral | 1 | 2018 | 1083 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2020 | 3608 | 0.03 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.03 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Proteome | 1 | 2020 | 1812 | 0.03 | Why? |
| Software | 1 | 2021 | 2501 | 0.02 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| RNA, Viral | 1 | 2017 | 32276 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Mexico | 1 | 2017 | 2787 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.02 | Why? |
| Virus Replication | 2 | 2020 | 14331 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2018 | 9335 | 0.02 | Why? |
| Carrier State | 1 | 2018 | 2100 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Brazil | 1 | 2017 | 12582 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
Caskey's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(151)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_